TO 13
Alligator Bioscience carried out a rights issue of units during December 2024 – February 2025. Each unit issued in the Rights Issue consisted of ten (10) ordinary shares, ten (10) warrants series TO 12 and five (5) warrants series TO 13. A total of 7,650,084,630 warrants series TO 13 were issued in the Rights Issue. In addition, in February 2025 and in connection with the Rights Issue and a renegotiation of an outstanding loan, the Board of Directors of the Company resolved on two directed issues of 2,172,800,000 warrants series TO 13 in total. The total number of outstanding warrants series TO 13 thus amounts to 9,822,884,630 (equivalent to 9,822,884 new shares post the reverse split in April 2025).
Timeline
- ~28 August 2025 – Announcement of exercise price
- 1 September 2025 – 15 September 2025 – Exercise period
- 11 September 2025 – Last day of trading with warrants
TO 12
Alligator Bioscience carried out a rights issue of units during December 2024 – February 2025. Each unit issued in the Rights Issue consisted of ten (10) ordinary shares, ten (10) warrants series TO 12 and five (5) warrants series TO 13. A total of 15,300,169,260 warrants series TO 12 were issued in the Rights Issue. In addition, in February 2025 and in connection with the Rights Issue and a renegotiation of an outstanding loan, the Board of Directors of the Company resolved on two directed issues of 4,345,600,000 warrants series TO 12 in total. The total number of outstanding warrants series TO 12 thus amounts to 19,645,769,260.
Timeline
- 28 April 2025 – Announcement of exercise price
- 5 May 2025 – 19 May 2025 – Exercise period
- 19 May 2025 – Last day of trading with warrants
The offering in summary
Alligator Bioscience announced on December 2, 2024 its decision to perform a preferential rights issue, subject to the subsequent approval of the Extra General Meeting.
The prospectus and other documents are found further down on this site.
Preliminary timeline
- 13 January 2025 – Extraordinary General Meeting – read more here
- 17 January 2025 – Publication of final terms of the Rights Issue, including Subscription Price
- 23 January 2025 – Last day of trading incl. preferential rights
- 24 January 2025 – Estimated publication of prospectus
- 24 January 2025 – First day of trading excl. preferential rights
- 27 January 2025 – Record date in the Rights Issue
- 29 January 2025 -7 February 2025 – Trading in unit rights
- 29 January 2025 – 12 February 2025 – Subscription period
- 14 February 2025 – Estimated publication of outcome in the Rights Issue
- 29 January 2025 – 4 March 2025 – Trading in paid subscribed units (Sw. “BTU”)
Interview with CFO Johan Giléus (in Swedish) >> link here <<.
